Detailed Information on Publication Record
2023
SEMISOLID HYDROPHILIC DRUG FORMS FOR LOCAL APPLICATION OF PSEUDOMONAS AERUGINOSA BACTERIOPHAGES
KOMÁRKOVÁ, Marie, Martin BENEŠÍK, Tereza ŠOPÍKOVÁ, Kateřina PLACHÁ, Filip RŮŽIČKA et. al.Basic information
Original name
SEMISOLID HYDROPHILIC DRUG FORMS FOR LOCAL APPLICATION OF PSEUDOMONAS AERUGINOSA BACTERIOPHAGES
Name in Czech
Polotuhé lékové formy pro lokální aplikaci bakteriofágů Pseudomonas aeruginosa
Name (in English)
SEMISOLID HYDROPHILIC DRUG FORMS FOR LOCAL APPLICATION OF PSEUDOMONAS AERUGINOSA BACTERIOPHAGES
Authors
KOMÁRKOVÁ, Marie, Martin BENEŠÍK, Tereza ŠOPÍKOVÁ, Kateřina PLACHÁ, Filip RŮŽIČKA and Roman PANTŮČEK
Edition
Targeting Phage Therapy 2023 World Congress, 2023
Other information
Language
Czech
Type of outcome
Konferenční abstrakt
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Organization unit
Faculty of Science
Keywords (in Czech)
bakteriofágy, Pseudomonas, hydrogel, mast, stabilita fága
Keywords in English
bacteriophages, Pseudomonas, hydrogel, ointment, phage stability
Změněno: 15/6/2023 11:52, Mgr. Marie Komárková
Abstract
V originále
We focused on three phages with variant morphology i.e., myovirus PA1, siphovirus PA10, and podovirus LUZ19. Every phage was mixed with carbomer gel and macrogol ointment. Their stabilities were assessed by drop test with the sensitive pseudomonal strains for five weeks. In the macrogol ointment, the myovirus PA1 has the highest titer decrease (i.e., four orders), in contrast with carbomer gel, when the most significant titer reduction was in the case of siphovirus PA10 (i.e., two orders). Generally, the phage stability in macrogol ointment was worse than in carbomer gel. This difference was probably caused by variant features of these drug forms, especially viscosity and antimicrobial effect. This study pointed out essential facts about the formulation and assessment of semisolid drug forms containing pseudomonal bacteriophages for the therapy of wound infections.
Links
LX22NPO5103, research and development project |
|